These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7448711)

  • 1. Malignant melanoma: influence of site of lesion and age of patient in the female superiority in survival.
    Shaw HM; McGovern VJ; Milton GW; Farago GA; McCarthy WH
    Cancer; 1980 Dec; 46(12):2731-5. PubMed ID: 7448711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The female superiority in survival in clinical stage II cutaneous malignant melanoma.
    Shaw HM; McGovern VJ; Milton GW; Farago GA; McCarthy WH
    Cancer; 1982 May; 49(9):1941-4. PubMed ID: 7074591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant melanoma in the elderly.
    Cohen HJ; Cox E; Manton K; Woodbury M
    J Clin Oncol; 1987 Jan; 5(1):100-6. PubMed ID: 3806154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (less than or equal to 1.5 mm) melanoma.
    Kuehnl-Petzoldt C; Keil H; Schoepf E
    Arch Dermatol Res; 1984; 276(3):151-5. PubMed ID: 6476888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic features of tumors and the female superiority in survival from malignant melanoma.
    Shaw HM; McGovern VJ; Milton GW; Farago GA; McCarthy WH
    Cancer; 1980 Apr; 45(7):1604-8. PubMed ID: 7370919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of a polypoid configuration in malignant melanoma.
    McGovern VJ; Shaw HM; Milton GW
    Histopathology; 1983 Sep; 7(5):663-72. PubMed ID: 6629342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in survival from cutaneous melanoma.
    Rampen FH
    Int J Dermatol; 1984 Sep; 23(7):444-52. PubMed ID: 6386712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival advantage of women in localized melanoma mainly relies on clinical-pathological differences by sex. A retrospective study of 1,607 patients in Valencia, Spain.
    Kindem S; Garcías-Ladaria J; Requena C; Guillén C; Oliver V; Nagore E
    Eur J Dermatol; 2015; 25(3):247-54. PubMed ID: 25961331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
    Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
    J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
    Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
    Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic parameters in localised melanoma: gender versus anatomical location.
    Karakousis CP; Driscoll DL
    Eur J Cancer; 1995; 31A(3):320-4. PubMed ID: 7786595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant melanoma in American black females: an unusual distribution of primary sites.
    Muchmore JH; Mizuguchi RS; Lee C
    J Am Coll Surg; 1996 Nov; 183(5):457-65. PubMed ID: 8912614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Gloves-and-socks" melanoma: does histology make a difference?
    Soudry E; Gutman H; Feinmesser M; Gutman R; Schachter J
    Dermatol Surg; 2008 Oct; 34(10):1372-8. PubMed ID: 18616532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of cutaneous malignant melanoma patients at University of Iowa Hospitals: 1950--1974.
    Griffel M
    Cancer; 1981 Jan; 47(1):176-83. PubMed ID: 7459806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
    Sahin S; Rao B; Kopf AW; Lee E; Rigel DS; Nossa R; Rahman IJ; Wortzel H; Marghoob AA; Bart RS
    Cancer; 1997 Oct; 80(8):1426-31. PubMed ID: 9338466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival among patients with clinical stage I cutaneous malignant melanoma diagnosed in Western Australia in 1975/1976 and 1980/1981.
    Heenan PJ; English DR; Holman CD; Armstrong BK
    Cancer; 1991 Nov; 68(9):2079-87. PubMed ID: 1913557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-year-survival in malignant melanoma related to sex and tumor location.
    Weidner F
    Dermatologica; 1981; 162(1):51-60. PubMed ID: 7227607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group.
    MacKie RM; Hole D; Hunter JA; Rankin R; Evans A; McLaren K; Fallowfield M; Hutcheon A; Morris A
    BMJ; 1997 Nov; 315(7116):1117-21. PubMed ID: 9374883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis in malignant melanoma of the skin. Significance of stage of disease, anatomical site, sex, age and period of diagnosis.
    Magnus K
    Cancer; 1977 Jul; 40(1):389-97. PubMed ID: 880566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mortality of invasive malignant cutaneous melanoma. A review with special consideration of gender distribution].
    Kölmel KF; Lippold A; Kulle B; Veltmaat S; Stoltenberg M; Seebacher C
    Hautarzt; 2001 Mar; 52(3):211-8. PubMed ID: 11284066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.